Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage
Gladtke, E.
Die Medizinische Welt 32(7): 219-224
1981
ISSN/ISBN: 0025-8512 PMID: 7207158 Document Number: 175309
Document emailed within 1 workday
Related Documents
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168Fürtig, W.; Heydel, E.; Box, A. 1984: Pharmacokinetic mechanisms of drug interactions. 1. General problems Die Pharmazie 39(1): 71-73
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Wagner, J.G.; Weidler, D.J.; Lin, Y.J. 1976: New method for detecting and quantitating pharmacokinetic drug-drug interactions applied to ethanol-propranolol Research Communications in Chemical Pathology and Pharmacology 13(1): 9-18
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Pfeifer, S. 1995: Pharmacokinetic drug interactions. Part 3: Drugs P-Z Die Pharmazie 50(5): 307-332
Man'kovskiĭ, N.B.; Mints, A.Ia. 1985: Current problems of drug therapy in neurogeriatrics Vrachebnoe Delo 1985(3): 106-111
Ecker-Schlipf, B. 1987: Disease and drug abuse. Current problems in drug safety Medizinische Monatsschrift für Pharmazeuten 10(8): 254-261
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Descotes, J.; Simonet, R.; Loupi, E.; Evreux, J.C. 1986: Drug interactions due to enzymatic inhibition. the predictive value of pharmacokinetic studies Therapie 41(5): 349-351
Bachmann, K.; Sullivan, T.J.; Fraiwat, T. 1988: Quantitative comparisons of pharmacokinetic drug interactions: a probabilistic approach Methods and Findings in Experimental and Clinical Pharmacology 10(11): 711-716
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Patat, A. 1995: Drug interactions: methological problems Therapie 50(3): 203-214
Kanarkowski, R.; Targońska, A. 1978: Various problems of clinical psychopharmacology (pharmacokinetics and drug interactions) Psychiatria Polska 12(2): 263-272